Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Gleim

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 LigaseKlemens Hoegenauer, Shaojian An, Jake Axford, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Cell Chemical Biology|April 1, 2021
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolismHyelim Cho, Qiong Shen, Lydia H Zhang, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Communications|August 19, 2024
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Chemical Biology|March 7, 2020
Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Nature Chemical Biology|December 11, 2019
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 LigaseKlemens Hoegenauer, Shaojian An, Jake Axford, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Cell Chemical Biology|April 1, 2021
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolismHyelim Cho, Qiong Shen, Lydia H Zhang, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Communications|August 19, 2024
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Chemical Biology|March 7, 2020
Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Nature Chemical Biology|December 11, 2019
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Pageof 3